Embed AI clinically in measurable, sustainable and trusted ways
Embed AI clinically in measurable, sustainable and trusted ways | Healthcare IT News
Skip to main content
Sometimes, it is not a hack. It is a misunderstanding. That is what Lovable is saying after concerns surfaced about sensitive data appearing in public projects. On 20 April 2026, the company clarified that its systems were not compromised, and the issue stemmed from how “public” settings were defined. But the episode has sparked a…
For decades, enterprise software promised to unlock productivity. It largely delivered on the transactional layer: routing approvals, syncing data, automating invoices. But the harder work of synthesizing unstructured information, exercising judgment, and producing nuanced written outputs has largely stayed with people. That dynamic appears to be shifting. AI agents are entering the enterprise not as…
Piotr Sobolewski, co-founder and CTO of HyperDev. Skills development organisation HyperionDev has introduced a generative artificial intelligence (AI) coding platform that seeks to become a bridge between experimental AI tools and production-ready software development. HyperDev is an AI app builder that lets users go from plain language to running code. The venture is created by…
The recent United States v. Heppner case highlights that inputs and outputs from public AI tools are not automatically confidential and may not be protected by attorney-client privilege or work …
1. What makes a good Generative AI company in 2026? A top-notch Generative AI company in 2026 creates systems that remain precise, budget-friendly, and reliable. It prioritizes how data is brought together, kept track of, and managed, ensuring AI keeps running smoothly long after it’s first put to use, not just during initial tests. 2….
A major leap in computational drug development has emerged with Roche’s launch of its global AI factory, powered by more than 3,500 NVIDIA Blackwell GPUs. This hybrid-cloud system integrates artificial intelligence across both early-stage drug discovery and downstream manufacturing pipelines. By leveraging NVIDIA’s healthcare AI platform, Roche aims to scale biological modeling at a level…